Market Overview

According to fortune business insights, the global exosome research market size was valued at USD 159.1 million in 2025. The market is projected to grow from USD 177.5 million in 2026 to USD 458.8 million by 2034, exhibiting a CAGR of 12.61% during the forecast period. North America dominated the global exosome research market with a market share of 43.37% in 2025.

The analysis shows that a rising global cancer burden and a strong emphasis on biomarker discovery are driving demand for exosome research tools. Exosomes are increasingly studied for their role in biomarker discovery, disease mechanism studies, and the development of novel therapeutic delivery systems. This trend indicates strong demand for exosome research technologies worldwide.

Major Players Profiled in the Market Report:

• Thermo Fisher Scientific Inc. (U.S.)
• QIAGEN (Germany)
• Lonza (Switzerland)
• System Biosciences, LLC. (U.S.)
• Danaher (U.S.)
• FUJIFILM Corporation (FUJIFILM Wako Pure Chemical Corporation) (Japan)
• IZON Science LTD (New Zealand)
• STEMCELL Technologies (Canada)
• RoosterBio, Inc. (U.S.)
• Spectris (U.S.)

Segments

Higher Usage of Kits and Reagents to Propel Products Segment Growth

Based on offering, the market is divided into products and services. The product segment holds the largest market share owing to the high and recurring usage of reagents and kits for exosome research applications.

Crucial Role in Research to Drive Isolation & Purification Segment Expansion

By workflow, the market is categorized into isolation & purification, characterization, profiling, and others. The isolation & purification segment is leading the market as this is the critical first step for all downstream activities, and laboratories spend heavily on these repeat-purchase products across large sample volumes.

Strong Focus on Early Detection to Drive Biomarker Discovery & Liquid Biopsy Research Segment